Effect of administration of intravenous intralipid on implantation rate in women with implantation failure after IVF/ICSI with non-donor oocytes: A randomized controlled trial.

All India Institute of Medical Sciences Delhi0 个研究点目标入组 102 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. History of one or more previously failed IVF/ICSI cycle.
•2. Age 25 to 40 years
•3. BMI in range of 20 to 32
•4. Normal hormonal profile as assessed by DAY 2 FSH, LH, TSH, Prolactin, and AMH
•5. Normal uterine cavity, as assessed by hysteroscopy or 3D ultrasonography.
•6. Written consent to participate in trial

•1. Women with obvious anatomical causes for implantation failure like fibroids, abnormal hysteroscopy or ultrasonography findings
•2. Donor oocyte IVF / ICSI
•3. Age more than 40 years
•4. Abnormal parental karyotype
•5. BMI more than 27
•6. Poor quality embryos as graded by SART morphological grade
•7. Immunological and medical comorbidities like connective tissue disorders, diabetes, congenital or acquired blood dyscrasias
•8. Clinical or laboratory findings of congenital or acquired thrombophilia.
•9. Severe male factor infertility requiring surgical sperm retrievals.
•10. Known history of allergic predisposition with known or possible allergy to soy products, lecithin , egg products
•11. Mental illness which renders the patient unable to understand the nature of the trial

发起方

All India Institute of Medical Sciences Delhi